Form 4: Avid Bioservices CEO Nicholas Green Reports Stock Transactions
SEC Form 4
Nicholas Green, President & CEO of Avid Bioservices, reports the acquisition and disposal of common stock and restricted stock units.
Summary
- On October 9, 2024, Nicholas Green, the President & CEO of Avid Bioservices, acquired 31,512 shares of common stock through the vesting of restricted stock units.
- On the same day, Green disposed of 5,573, 8,826, and 17,113 restricted stock units.
- On October 10, 2024, Green sold 17,173 shares of common stock at a weighted average price of $10.05 per share to satisfy tax withholding obligations related to the vesting of RSUs.
- Following these transactions, Green directly owns 226,653 shares of common stock and 482,914 restricted stock units.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The transactions are routine and related to executive compensation. The sale of shares is for tax purposes and doesn't necessarily indicate a lack of confidence in the company.
Positives
- The acquisition of shares through RSU vesting indicates confidence in the company's future performance.
Negatives
- The sale of shares, even for tax obligations, could be perceived negatively by some investors.
Risks
- Executive stock sales, even for tax purposes, can sometimes create short-term price volatility.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies and are closely monitored by investors for insights into management's perspective on the company's valuation and future prospects.
Comparison to Industry Standards
- Executive compensation packages often include restricted stock units that vest over time, aligning management's interests with those of shareholders.
- Sales of shares to cover tax obligations are a standard practice among executives receiving equity compensation.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the potential for short-term price fluctuations.
Key Dates
| Date | Description |
|---|---|
| July 9, 2021 | RSUs granted to the reporting person on July 9, 2021, vest in sixteen (16) equal quarterly installments over a four (4) year period beginning October 9, 2021, and each quarter thereafter until fully-vested. |
| October 9, 2021 | Vesting start date for RSUs granted on July 9, 2021. |
| July 9, 2022 | RSUs granted to the reporting person on July 9, 2022, vest in sixteen (16) equal quarterly installments over a four (4) year period beginning October 9, 2022, and each quarter thereafter until fully-vested. |
| October 9, 2022 | Vesting start date for RSUs granted on July 9, 2022. |
| July 9, 2024 | RSUs granted to the reporting person on July 9, 2024, vest in sixteen (16) equal quarterly installments over a four (4) year period beginning October 9, 2024, and each quarter thereafter until fully-vested. |
| October 9, 2024 | Date of transaction involving acquisition of shares through RSU vesting and disposal of RSUs. |
| October 9, 2024 | Vesting start date for RSUs granted on July 9, 2024. |
| October 10, 2024 | Date of transaction involving the sale of shares to cover tax obligations. |
| October 11, 2024 | Date of signature for the Form 4 filing. |
Keywords
Avid Bioservices, CDMO, Nicholas Green, stock, restricted stock units, Form 4, insider trading, executive compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.